Works matching IS 15069680 AND DT 2016 AND VI 19 AND IP 2

Results: 11

Editorial.

Published in:

2016

By:

Mikolajczak, Renata;
Kamiński, Grzegorz

Publication type:

Editorial

Radiopharmaceuticals for somatostatin receptor imaging.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 126, doi. 10.5603/NMR.2016.0024

By:

Mikotajczak, Renata;
Maecke, Helmut R.

Publication type:

Article

Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 99, doi. 10.5603/NMR.2016.0020

By:

Artiko, Vera;
Afgan, Aida;
Petrović, Jelena;
Radović, Branislava;
Petrović, Nebojša;
Vlajković, Marina;
Šobić-Šaranović, Dragana;
Obradović, Vladimir

Publication type:

Article

Oxidation of methionine -- is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 104, doi. 10.5603/NMR.2016.0021

By:

Janota, Barbara;
Karczmarczyk, Urszula;
Laszuk, Ewa;
Garnuszek, Piotr;
Mikołajczak, Renata

Publication type:

Article

NEN -- the role of somatostatin receptor scintigraphy in clinical setting.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 118, doi. 10.5603/NMR.2016.0023

By:

Opalinska, Marta;
Hubalewska-Dydejczyk, Alicja;
Sowa-Staszczak, Anna;
Stefanska, Agnieszka

Publication type:

Article

Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 81, doi. 10.5603/NMR.2016.0017

By:

Sergieva, Sonya;
Robev, Bozhil;
Dimcheva, Milena;
Fakirova, Albena;
Hristoskova, Radka

Publication type:

Article

Limitations and pitfalls of 99mTc-EDDA//HYNIC-TOC (Tektrotyd) scintigraphy.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 93, doi. 10.5603/NMR.2016.0019

By:

Garai, Ildiko;
Barna, Sándor;
Nagy, Gabor;
Forgács, Attila

Publication type:

Article

Neuroendocrine neoplasms and somatostatin receptor subtypes expression.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 111, doi. 10.5603/NMR.2016.0022

By:

Hankus, Jerzy;
Tomaszewska, Romana

Publication type:

Article

99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 67, doi. 10.5603/NMR.2016.0015

By:

Czepczyński, Rafał;
Gryczyńska, Maria;
Ruchała, Marek

Publication type:

Article

99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 74, doi. 10.5603/NMR.2016.0016

By:

Trogrlic, Mate;
Tezak, Stanko

Publication type:

Article

Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.

Published in:

Nuclear Medicine Review, 2016, v. 19, n. 2, p. 88, doi. 10.5603/NMR.2016.0018

By:

Mądrzak, Dorota;
Mikotajczak, Renata;
Kamiński, Grzegorz

Publication type:

Article

Works matching IS 15069680 AND DT 2016 AND VI 19 AND IP 2

Editorial.

Radiopharmaceuticals for somatostatin receptor imaging.

Evaluation of neuroendocrine tumors with <sup>99m</sup>Tc-EDDA/HYNIC TOC.

Oxidation of methionine -- is it limiting the diagnostic properties of <sup>99m</sup>Tc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?

NEN -- the role of somatostatin receptor scintigraphy in clinical setting.

Clinical application of SPECT-CT with <sup>99m</sup>Tc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).

Limitations and pitfalls of <sup>99m</sup>Tc-EDDA//HYNIC-TOC (Tektrotyd) scintigraphy.

Neuroendocrine neoplasms and somatostatin receptor subtypes expression.

<sup>99m</sup>Tc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.

<sup>99m</sup>Tc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.

Influence of PET/CT <sup>68</sup>Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with <sup>99m</sup>Tc-EDDA/HYNIC-TOC SPECT.